10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q2 2025

Filing Information

Form Type	10-Q
Accession Number	`0001628280-25-036713`
Period End Date	20250630
Filing Date	20250730
Fiscal Year	2025
Fiscal Period	Q2
XBRL Instance	alhc-20250630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 154 Income Statement 160 Cash Flow Statement 174 Stockholders Equity 66

Balance Sheet 154 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$262.00K	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$262.00K	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$470.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$470.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$339.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$339.01M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $262 at June 30, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$153.90M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $262 at June 30, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$153.90M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $262 at June 30, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$282.93M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $262 at June 30, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$282.93M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$37.79M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$37.79M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$33.51M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$33.51M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$37.08M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$37.08M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$93.41M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$93.41M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$880.12M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$880.12M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$661.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$661.64M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	197.96M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	197.96M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$67.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$67.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$69.52M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$69.52M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.78M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.78M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	197.96M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	197.96M	shares	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.58M	USD	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.58M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.82M	USD	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.82M	USD	Point-in-time
Goodwill	`Goodwill`	$32.06M	USD	Point-in-time
Goodwill	`Goodwill`	$32.06M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.09M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.09M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.32M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.32M	USD	Point-in-time
Total assets	`Assets`	$1.00B	USD	Point-in-time
Total assets	`Assets`	$1.00B	USD	Point-in-time
Total assets	`Assets`	$782.06M	USD	Point-in-time
Total assets	`Assets`	$782.06M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$289.79M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$289.79M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$455.15M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$455.15M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.13M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.13M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$31.36M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$31.36M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$39.93M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$39.93M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$43.02M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$43.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$351.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$351.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$529.53M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$529.53M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$321.43M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$321.43M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$322.30M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$322.30M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.83M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.83M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.36M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.36M	USD	Point-in-time
Total liabilities	`Liabilities`	$859.18M	USD	Point-in-time
Total liabilities	`Liabilities`	$859.18M	USD	Point-in-time
Total liabilities	`Liabilities`	$681.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$681.11M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of June 30, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of June 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of June 30, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of June 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of June 30, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of June 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of June 30, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of June 30, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 197,958,237 and 191,778,639 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$198.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 197,958,237 and 191,778,639 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$198.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 197,958,237 and 191,778,639 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$192.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 197,958,237 and 191,778,639 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$192.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.11B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.11B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.14B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.00B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.00B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$140.97M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$140.97M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$99.85M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$99.85M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.10M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.00B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.00B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$782.06M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$782.06M	USD	Point-in-time

Income Statement 160 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$1.01B	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$1.01B	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$674.09M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$674.09M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$1.30B	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.30B	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.92B	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.92B	USD	2 Qtrs
Other	`OtherIncome`	$17.97M	USD	2 Qtrs
Other	`OtherIncome`	$17.97M	USD	2 Qtrs
Other	`OtherIncome`	$9.09M	USD	1 Quarter
Other	`OtherIncome`	$9.09M	USD	1 Quarter
Other	`OtherIncome`	$7.19M	USD	1 Quarter
Other	`OtherIncome`	$7.19M	USD	1 Quarter
Other	`OtherIncome`	$14.24M	USD	2 Qtrs
Other	`OtherIncome`	$14.24M	USD	2 Qtrs
Total revenues	`Revenues`	$1.02B	USD	1 Quarter
Total revenues	`Revenues`	$1.02B	USD	1 Quarter
Total revenues	`Revenues`	$681.29M	USD	1 Quarter
Total revenues	`Revenues`	$681.29M	USD	1 Quarter
Total revenues	`Revenues`	$1.31B	USD	2 Qtrs
Total revenues	`Revenues`	$1.31B	USD	2 Qtrs
Total revenues	`Revenues`	$1.94B	USD	2 Qtrs
Total revenues	`Revenues`	$1.94B	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$1.18B	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$1.18B	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$881.74M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$881.74M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$1.70B	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$1.70B	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$605.31M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$605.31M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$103.80M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$103.80M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$207.63M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$207.63M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$178.38M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$178.38M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$87.86M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$87.86M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.49M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.49M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.60M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.60M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.47M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.47M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.00M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.37B	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$1.37B	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$992.54M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$992.54M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.92B	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$1.92B	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$699.67M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$699.67M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-18.38M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-18.38M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-59.49M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-59.49M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$22.75M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$22.75M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$17.36M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$17.36M	USD	2 Qtrs
Interest expense	`InterestExpenseNonoperating`	$3.95M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$3.95M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.69M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.69M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$11.12M	USD	2 Qtrs
Interest expense	`InterestExpenseNonoperating`	$11.12M	USD	2 Qtrs
Interest expense	`InterestExpenseNonoperating`	$7.90M	USD	2 Qtrs
Interest expense	`InterestExpenseNonoperating`	$7.90M	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$92.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$92.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$50.00K	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$50.00K	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$89.00K	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$89.00K	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$79.00K	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$79.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-11.07M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-11.07M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-3.87M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-3.87M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-7.81M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-7.81M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-5.60M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-5.60M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.54M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.54M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$18.88M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$18.88M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.98M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.98M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-70.56M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-70.56M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.00K	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.00K	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.22M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.22M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.25M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.25M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$15.65M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$15.65M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.30M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$6.30M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-47.00K	USD	2 Qtrs
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-47.00K	USD	2 Qtrs
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00K	USD	1 Quarter
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00K	USD	1 Quarter
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-254.00K	USD	2 Qtrs
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-254.00K	USD	2 Qtrs
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-14.00K	USD	1 Quarter
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-14.00K	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-24.01M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-24.01M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$15.67M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$15.67M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$6.55M	USD	2 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$6.55M	USD	2 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-70.53M	USD	2 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-70.53M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.03	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.03	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.37	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.37	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.07	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.07	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.37	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.37	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.03	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.03	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	189.95M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	189.95M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	190.89M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	190.89M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	195.98M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	195.98M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	198.33M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	198.33M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	209.52M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	209.52M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	190.89M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	190.89M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	201.58M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	201.58M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	189.95M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	189.95M	shares	2 Qtrs

Cash Flow Statement 174 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$15.65M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$15.65M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.30M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$6.30M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$95.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$95.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$262.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$262.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$95.00K	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$95.00K	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$262.00K	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$262.00K	USD	2 Qtrs
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-143.00K	USD	2 Qtrs
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-143.00K	USD	2 Qtrs
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	-	USD	2 Qtrs
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	-	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$72.00K	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$72.00K	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$12.57M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$12.57M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$14.66M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$14.66M	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.76M	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.76M	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$731.00K	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$731.00K	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$881.00K	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$881.00K	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$612.00K	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$612.00K	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$37.64M	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$37.64M	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$32.74M	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$32.74M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$246.00K	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$246.00K	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$930.00K	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$930.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$63.56M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$63.56M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$129.26M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$129.26M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.22M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.22M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$56.33M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$56.33M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$52.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$52.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-92.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-92.00K	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$165.37M	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$165.37M	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$109.97M	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$109.97M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$8.55M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$8.55M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.37M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.37M	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$77.00K	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$77.00K	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-310.00K	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-310.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.28M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.28M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$3.08M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$3.08M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.42M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.42M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$20.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$20.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$17.29M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$17.29M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$45.75M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$45.75M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$40.00M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$40.00M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$35.00M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$35.00M	USD	2 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$75.00K	USD	2 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$75.00K	USD	2 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$39.99M	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$39.99M	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$132.53M	USD	2 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$132.53M	USD	2 Qtrs
Sale of business	`ProceedsFromDivestitureOfBusinesses`	$1.06M	USD	2 Qtrs
Sale of business	`ProceedsFromDivestitureOfBusinesses`	$1.06M	USD	2 Qtrs
Sale of business	`ProceedsFromDivestitureOfBusinesses`	-	USD	2 Qtrs
Sale of business	`ProceedsFromDivestitureOfBusinesses`	-	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.25M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.25M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.85M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.85M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$69.67M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$69.67M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.13M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.13M	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$50.00M	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$50.00M	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	2 Qtrs
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$512.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$512.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$26.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$26.00K	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$1.82M	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$1.82M	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	-	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	-	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.80M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.80M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.15M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$49.15M	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$37.42M	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$37.42M	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$136.12M	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$136.12M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$472.36M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$472.36M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$472.36M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$472.36M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$10.25M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$10.25M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$6.74M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$6.74M	USD	2 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$122.00K	USD	2 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$122.00K	USD	2 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$117.00K	USD	2 Qtrs
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$117.00K	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$470.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$470.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$339.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$339.01M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.09M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.09M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.06M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.06M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$341.07M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$472.36M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$472.36M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time

Stockholders Equity 66 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	197.96M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	197.96M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$15.65M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$15.65M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-24.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.30M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$6.30M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-70.58M	USD	2 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$2.00K	USD	2 Qtrs
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$2.00K	USD	2 Qtrs
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	2 Qtrs
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	2 Qtrs
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$16.78M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$16.78M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$32.74M	USD	2 Qtrs
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$32.74M	USD	2 Qtrs
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$37.64M	USD	2 Qtrs
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$37.64M	USD	2 Qtrs
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$15.55M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$15.55M	USD	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	24,472.00	shares	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	24,472.00	shares	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	99,107.00	shares	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	99,107.00	shares	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.62M	USD	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.62M	USD	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.82M	USD	2 Qtrs
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.82M	USD	2 Qtrs
Sale of consolidated subsidiary	`NoncontrollingInterestDecreaseFromDeconsolidation`	$850.00K	USD	1 Quarter
Sale of consolidated subsidiary	`NoncontrollingInterestDecreaseFromDeconsolidation`	$850.00K	USD	1 Quarter
Sale of consolidated subsidiary	`NoncontrollingInterestDecreaseFromDeconsolidation`	$850.00K	USD	2 Qtrs
Sale of consolidated subsidiary	`NoncontrollingInterestDecreaseFromDeconsolidation`	$850.00K	USD	2 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	2 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	2 Qtrs
Ending balance (in shares)	`CommonStockSharesOutstanding`	197.96M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	197.96M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$140.97M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$124.80M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.